Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-31

Clinical Trial Update: Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of GED-0507-34-Levo for ulcerative colitis was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GED-0507-34-Levo

Snippet

Sponsor: PPM Services S.A. | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED | Results posted: 2018-10-31